Different properties of BCR signaling have been identified in normal B cells and in lymphoma B cells from follicular lymphoma patients[20,21], and impaired BCR signaling identified a subset of follicular lymphoma tumor cells with negative prognostic impact on patients overall survival[22]. The gene discussed is BCR; the disease is follicular lymphoma.